APC and cancer: Deregulation of Wnt signaling contributes to many cancers, resulting from both activating mutations of the proto-oncogene CTNNB1 (encoding β-catenin), and loss of function mutations in negative regulators of the pathway, such as APC (encoding Adenomatous Polyposis Coli).